메뉴 건너뛰기




Volumn 28, Issue 5, 2003, Pages 374-379

B-type natriuretic peptide - Current use in the diagnosis and management of heart failure;B-typ-natriuretisches peptid - Aktueller stellenwert in der diagnostik und therapieoptimierung der herzinsuffizienz

Author keywords

Diagnosis; Dyspnea; Heart failure; Natriuretic peptide

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

EID: 17544401610     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-003-2415-x     Document Type: Review
Times cited : (2)

References (48)
  • 1
    • 0028359997 scopus 로고
    • Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
    • Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
    • (1994) Circulation , vol.90 , pp. 195-203
    • Yasue, H.1    Yoshimura, M.2    Sumida, H.3
  • 3
    • 0027190324 scopus 로고
    • Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction
    • Lerman A, Gibbons RJ, Rodeheffer RJ, et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341:1105-9.
    • (1993) Lancet , vol.341 , pp. 1105-1109
    • Lerman, A.1    Gibbons, R.J.2    Rodeheffer, R.J.3
  • 4
    • 0029783064 scopus 로고    scopus 로고
    • Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment
    • Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 1996;76:232-7.
    • (1996) Heart , vol.76 , pp. 232-237
    • Omland, T.1    Aakvaag, A.2    Vik-Mo, H.3
  • 5
    • 0029885046 scopus 로고    scopus 로고
    • Comparison of atrial natriuretic peptide B-type natriuretic peptide and N-terminal pro-atrial natriuretic peptide as indicators of left ventricular systolic dysfunction
    • Davidson NC, Naas AA, Hanson JK, et al. Comparison of atrial natriuretic peptide B-type natriuretic peptide and N-terminal pro-atrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 1996;77:828-31.
    • (1996) Am J Cardiol , vol.77 , pp. 828-831
    • Davidson, N.C.1    Naas, A.A.2    Hanson, J.K.3
  • 6
    • 0029834931 scopus 로고    scopus 로고
    • Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
    • Yamamoto K, Burnett JC Jr, Jougasaki M, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-94.
    • (1996) Hypertension , vol.28 , pp. 988-994
    • Yamamoto, K.1    Burnett J.C., Jr.2    Jougasaki, M.3
  • 7
    • 0032477567 scopus 로고    scopus 로고
    • Biochemical detection of left-ventricular systolic dysfunction
    • McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
    • (1998) Lancet , vol.351 , pp. 9-13
    • McDonagh, T.A.1    Robb, S.D.2    Murdoch, D.R.3
  • 8
    • 0033864121 scopus 로고    scopus 로고
    • Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population
    • Luchner A, Burnett JC Jr, Jougasaki M, et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 2000;18:1121-8.
    • (2000) J Hypertens , vol.18 , pp. 1121-1128
    • Luchner, A.1    Burnett J.C., Jr.2    Jougasaki, M.3
  • 9
    • 0034820724 scopus 로고    scopus 로고
    • Utility of B-natriuretic peptide in identifying patients with left ventricular systolic or diastolic dysfunction
    • Krishnaswamy P, Lubien E, Clopton P, et al. Utility of B-natriuretic peptide in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001;111:274-9.
    • (2001) Am J Med , vol.111 , pp. 274-279
    • Krishnaswamy, P.1    Lubien, E.2    Clopton, P.3
  • 10
    • 0035091745 scopus 로고    scopus 로고
    • Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction
    • Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001;141:367-74.
    • (2001) Am Heart J , vol.141 , pp. 367-374
    • Maisel, A.S.1    Koon, J.2    Krishnaswamy, P.3
  • 11
    • 0037022231 scopus 로고    scopus 로고
    • Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings
    • Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings. Circulation 2002;105:595-601.
    • (2002) Circulation , vol.105 , pp. 595-601
    • Lubien, E.1    DeMaria, A.2    Krishnaswamy, P.3
  • 12
    • 0027162016 scopus 로고
    • Natriuretic peptide system in human heart failure
    • Wei CH, Heublein DM, Perella MA et al. Natriuretic peptide system in human heart failure. Circulation 1993;88:1004-49.
    • (1993) Circulation , vol.88 , pp. 1004-1049
    • Wei, C.H.1    Heublein, D.M.2    Perella, M.A.3
  • 13
    • 0028158397 scopus 로고
    • Plasma brain natriuretic peptide in assessment of acute dyspnea
    • Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet 1994;343:440-4.
    • (1994) Lancet , vol.343 , pp. 440-444
    • Davis, M.1    Espiner, E.2    Richards, G.3
  • 14
    • 0031573250 scopus 로고    scopus 로고
    • Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
    • Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-53.
    • (1997) Lancet , vol.350 , pp. 1349-1353
    • Cowie, M.R.1    Struthers, A.D.2    Wood, D.A.3
  • 15
    • 0035133323 scopus 로고    scopus 로고
    • Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting
    • Dao Q, Krishnaswamy P, Kasanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379-85.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 379-385
    • Dao, Q.1    Krishnaswamy, P.2    Kasanegra, R.3
  • 16
    • 0035680857 scopus 로고    scopus 로고
    • Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea
    • Cabanes L, Richard-Thiriez B, Fulla Y, et al. Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea. Chest 2001;120:2047-50.
    • (2001) Chest , vol.120 , pp. 2047-2050
    • Cabanes, L.1    Richard-Thiriez, B.2    Fulla, Y.3
  • 17
    • 0037116539 scopus 로고    scopus 로고
    • Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea
    • Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002;39:202-9.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 202-209
    • Morrison, L.K.1    Harrison, A.2    Krishnaswamy, P.3
  • 18
    • 0037130155 scopus 로고    scopus 로고
    • Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
    • Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
    • (2002) N Engl J Med , vol.347 , pp. 161-167
    • Maisel, A.S.1    Krishnaswamy, P.2    Nowak, R.M.3
  • 19
    • 17944374924 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of chronic heart failure
    • Remme WJ, Swedberg K, Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.
    • (2001) Eur Heart J , vol.22 , pp. 1527-1560
    • Remme, W.J.1    Swedberg, K.2
  • 20
    • 0031862908 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
    • Maeda K, Tsutamoto T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-32.
    • (1998) Am Heart J , vol.135 , pp. 825-832
    • Maeda, K.1    Tsutamoto, T.2    Wada, A.3
  • 21
    • 0035068002 scopus 로고    scopus 로고
    • A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study
    • Kazanegra R, Cheng V, Garcia A, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 2001;7:21-6.
    • (2001) J Card Fail , vol.7 , pp. 21-26
    • Kazanegra, R.1    Cheng, V.2    Garcia, A.3
  • 22
    • 0030806988 scopus 로고    scopus 로고
    • Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
    • Tsutamoto T, Wada A, Maeda K. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-16.
    • (1997) Circulation , vol.96 , pp. 509-516
    • Tsutamoto, T.1    Wada, A.2    Maeda, K.3
  • 23
    • 0032939391 scopus 로고    scopus 로고
    • Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction
    • Australia-New Zealand Heart Failure Group
    • Richards AM, Doughty R, Nichols MG, et al., Australia-New Zealand Heart Failure Group. Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Circulation 1999;99:786-92.
    • (1999) Circulation , vol.99 , pp. 786-792
    • Richards, A.M.1    Doughty, R.2    Nichols, M.G.3
  • 24
    • 0034332845 scopus 로고    scopus 로고
    • High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure
    • Maeda K, Tsutamoto T, Wada A, et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000;36:1587-93.
    • (2000) J Am Coll Cardiol , vol.36 , pp. 1587-1593
    • Maeda, K.1    Tsutamoto, T.2    Wada, A.3
  • 25
    • 0035137489 scopus 로고    scopus 로고
    • A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study
    • Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001;37:386-91.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 386-391
    • Cheng, V.1    Kazanagra, R.2    Garcia, A.3
  • 26
    • 0035369468 scopus 로고    scopus 로고
    • Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin. Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction
    • Richards AM, Doughty R, Nicholls MG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin. Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 2001;37:1781-7.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 1781-1787
    • Richards, A.M.1    Doughty, R.2    Nicholls, M.G.3
  • 27
    • 0035204418 scopus 로고    scopus 로고
    • Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure
    • Koglin J, Pehlivanli S, Schwaiblmair M, et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001;38:1934-41.
    • (2001) J Am Coll Cardiol , vol.38 , pp. 1934-1941
    • Koglin, J.1    Pehlivanli, S.2    Schwaiblmair, M.3
  • 28
    • 0035204653 scopus 로고    scopus 로고
    • Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems
    • Sodian R, Loebe M, Schmitt C, et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol 2001;38:1942-9.
    • (2001) J Am Coll Cardiol , vol.38 , pp. 1942-1949
    • Sodian, R.1    Loebe, M.2    Schmitt, C.3
  • 29
    • 0036161096 scopus 로고    scopus 로고
    • B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea
    • Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002;39:131-8.
    • (2002) Ann Emerg Med , vol.39 , pp. 131-138
    • Harrison, A.1    Morrison, L.K.2    Krishnaswamy, P.3
  • 30
    • 0037085959 scopus 로고    scopus 로고
    • Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure
    • Ishij J, Nomura M, Nakamura Y, et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 2002;89:691-5.
    • (2002) Am J Cardiol , vol.89 , pp. 691-695
    • Ishij, J.1    Nomura, M.2    Nakamura, Y.3
  • 31
    • 17144452791 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension
    • Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998;31:202-8.
    • (1998) J Am Coll Cardiol , vol.31 , pp. 202-208
    • Nagaya, N.1    Nishikimi, T.2    Okano, Y.3
  • 32
    • 0034702908 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension
    • Nagaya N, Nishikimi T, Uematsu M, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000;102:865-70.
    • (2000) Circulation , vol.102 , pp. 865-870
    • Nagaya, N.1    Nishikimi, T.2    Uematsu, M.3
  • 33
    • 0035163117 scopus 로고    scopus 로고
    • Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism
    • Tulevski II, Hirsch A, Sanson BJ, et al. Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism. Thromb Haemost 2001;86:1193-6.
    • (2001) Thromb Haemost , vol.86 , pp. 1193-1196
    • Tulevski, I.I.1    Hirsch, A.2    Sanson, B.J.3
  • 34
    • 0032736511 scopus 로고    scopus 로고
    • Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy
    • Murdoch DR, McDonagh TA, Byrne J, et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 1999;138:1126-32.
    • (1999) Am Heart J , vol.138 , pp. 1126-1132
    • Murdoch, D.R.1    McDonagh, T.A.2    Byrne, J.3
  • 35
    • 0034176934 scopus 로고    scopus 로고
    • Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
    • Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-30.
    • (2000) Lancet , vol.355 , pp. 1126-1130
    • Troughton, R.W.1    Frampton, C.M.2    Yandle, T.G.3
  • 36
    • 0027312397 scopus 로고
    • Plasma brain natriuretic peptide as an indicator of angiotensin converting enzyme inhibition after myocardial infarction
    • Motwani JG, McAlpine H, Kennedy N, et al. Plasma brain natriuretic peptide as an indicator of angiotensin converting enzyme inhibition after myocardial infarction. Lancet 1993;341:1109-13.
    • (1993) Lancet , vol.341 , pp. 1109-1113
    • Motwani, J.G.1    McAlpine, H.2    Kennedy, N.3
  • 37
    • 0030220734 scopus 로고    scopus 로고
    • Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction
    • Darbar D, Davidson NC, Gillespie N, et al. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol 1996;78:284-7.
    • (1996) Am J Cardiol , vol.78 , pp. 284-287
    • Darbar, D.1    Davidson, N.C.2    Gillespie, N.3
  • 38
    • 0029948712 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long term survival after acute myocardial infarction
    • Omland T, Aakvaag A, Bonargee VVS, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long term survival after acute myocardial infarction. Circulation 1996;93:1963-9.
    • (1996) Circulation , vol.93 , pp. 1963-1969
    • Omland, T.1    Aakvaag, A.2    Bonargee, V.V.S.3
  • 39
    • 0033812338 scopus 로고    scopus 로고
    • Profile of plasma N-terminal proBNP following acute myocardial infarction. Correlation with left ventricular systolic dysfunction
    • Talwar S, Squire B, Downie PF, et al. Profile of plasma N-terminal proBNP following acute myocardial infarction. Correlation with left ventricular systolic dysfunction. Eur Heart J 2000;21:1514-21.
    • (2000) Eur Heart J , vol.21 , pp. 1514-1521
    • Talwar, S.1    Squire, B.2    Downie, P.F.3
  • 40
    • 0035807597 scopus 로고    scopus 로고
    • The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
    • De Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21.
    • (2001) N Engl J Med , vol.345 , pp. 1014-1021
    • De Lemos, J.A.1    Morrow, D.A.2    Bentley, J.H.3
  • 41
    • 0035886884 scopus 로고    scopus 로고
    • Usefulness of plasma brain natriuretic peptide after acute myocardial infarction in predicting left ventricular dilatation six months later
    • Hirayama A, Yamamoto H, Sakata Y, et al. Usefulness of plasma brain natriuretic peptide after acute myocardial infarction in predicting left ventricular dilatation six months later. Am J Cardiol 2001;88:890-3.
    • (2001) Am J Cardiol , vol.88 , pp. 890-893
    • Hirayama, A.1    Yamamoto, H.2    Sakata, Y.3
  • 42
    • 0037083217 scopus 로고    scopus 로고
    • Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes
    • Omland T, De Lemos JA, Morrow DA, et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol 2002;89:463-5.
    • (2002) Am J Cardiol , vol.89 , pp. 463-465
    • Omland, T.1    De Lemos, J.A.2    Morrow, D.A.3
  • 43
    • 0037117649 scopus 로고    scopus 로고
    • Multimarker approach to risk stratification in non-ST-elevation acute coronary syndromes. Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide
    • Sabatine MS, Morrow DA, De Lemos JA, et al. Multimarker approach to risk stratification in non-ST-elevation acute coronary syndromes. Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105: 1760-3.
    • (2002) Circulation , vol.105 , pp. 1760-1763
    • Sabatine, M.S.1    Morrow, D.A.2    De Lemos, J.A.3
  • 44
    • 0036238139 scopus 로고    scopus 로고
    • Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide
    • Nilsson JC, Groenningen BA, Nielson G, et al. Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide. Am Heart J 2002;143:696-702.
    • (2002) Am Heart J , vol.143 , pp. 696-702
    • Nilsson, J.C.1    Groenningen, B.A.2    Nielson, G.3
  • 45
    • 0026785561 scopus 로고
    • Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
    • The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327:685-91.
    • (1992) N Engl J Med , vol.327 , pp. 685-691
  • 46
    • 0037150210 scopus 로고    scopus 로고
    • B-type natriuretic peptide predicts sudden death in patients with chronic heart failure
    • Berger R, Huelsman M, Stecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002;105:2392-7.
    • (2002) Circulation , vol.105 , pp. 2392-2397
    • Berger, R.1    Huelsman, M.2    Stecker, K.3
  • 47
    • 0036023626 scopus 로고    scopus 로고
    • The impact of B-type natriuretic peptide levels on the diagnosis and management of congestive heart failure
    • Tabbibizar R, Maisel A. The impact of B-type natriuretic peptide levels on the diagnosis and management of congestive heart failure. Curr Opin Cardiol 2002;17:340-5.
    • (2002) Curr Opin Cardiol , vol.17 , pp. 340-345
    • Tabbibizar, R.1    Maisel, A.2
  • 48
    • 0037019567 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide concentration: Impact of age and gender
    • Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-82.
    • (2002) J Am Coll Cardiol , vol.40 , pp. 976-982
    • Redfield, M.M.1    Rodeheffer, R.J.2    Jacobsen, S.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.